EGI
VRNA

EAM Global Investors’s Verona Pharma VRNA Stock Holding History

EAM Global Investors’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-76,131
Closed -$7.2M – 76
2025
Q2 		$7.2M Sell
76,131
-59,896
-44% -$4.43M 1.87% 5
2025
Q1 		$8.64M Buy
136,027
+42
+0% +$2.51K 2.35% 3
2024
Q4 		$6.32M Buy
135,985
+85
+0.1% +$3.19K 1.13% 17
2024
Q3 		$3.91M Buy
+135,900
New +$3.34M 0.79% 81

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EAM Global Investors's VRNA Position: Q3 2025 in Review

EAM Global Investors sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 76,131 shares — an estimated $7.2M sold.

EAM Global Investors first reported a position in VRNA in Q3 2024 and held it in 4 quarters. The position peaked at $8.64M in Q1 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • EAM Global Investors reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • EAM Global Investors sold 76,131 Verona Pharma shares in Q3 2025, an estimated $7.2M.
  • EAM Global Investors first reported a position in Verona Pharma in Q3 2024 and held it in 4 quarters.
  • EAM Global Investors's Verona Pharma position peaked at $8.64M in Q1 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on EAM Global Investors's 13F filing for Q3 2025, filed 14 Nov 2025.